Abdul Mannan: Evidence-Based Anticoagulation Strategies for Children With VTE
Abdul Mannan, Consultant Hematologist at Betsi Cadwaladr University Health Board, shared a post on LinkedIn:
“Most pediatric thrombosis guidelines were written by adults.
Literally. They were extrapolated from adult data. For decades.
That just changed.
The ASH/ISTH 2024 Paediatric VTE Guidelines dropped in Blood Advances (May 2025).
First ever joint guidelines built specifically on paediatric evidence.
And some of it will surprise you:
- For a first provoked DVT in a child?
6 weeks of anticoagulation may be enough.
Not 3 months. Not 6 months. Six. Weeks.
(If the trigger is gone and risk is low)
- DOACs are now endorsed for children.
Rivaroxaban and dabigatran both have age-appropriate approvals.
- Weight-based dosing.
- Oral.
- No INR checks.
Kids don’t have to live on warfarin anymore.
- That CVAD clot you found on imaging?
If the line is working and the child is stable — you probably don’t need to remove it.
Anticoagulate. Keep the line. Reassess.
- Unsuspected PE in a child?
Treat it. Even if they look fine.
Silent doesn’t mean harmless.
The old ‘just use the adult dose and adjust’ era is over.
These guidelines represent real paediatric trial data — Diversity, Kids-DOTT, EINSTEIN-Jr, KIDS-DOTT. Proper evidence. Proper patients.
I built a free interactive clinical reference tool based on these guidelines — all 20 recommendations, evidence summaries, drug dosing tables, and decision support. No login. No paywall.
Bookmark it. Share it with your paediatric colleagues.
What surprises you most — the 6-week duration or DOACs in kids?”
More posts from Abdul Mannan on Hemostasis Today.
-
Sep 5, 2026, 19:20Yubrine Moraa Gachemba: BETULA Adds New Evidence for Catheter-Directed Thrombolysis in PE
-
Sep 5, 2026, 19:18John R. Mehall: The Importance of Anticoagulation Management in ECMO
-
Sep 5, 2026, 19:16Thirunavukkarasu Angappan: Why Hemophilia B Still Needs Both Plasma-Derived and Recombinant Factor IX
-
Sep 5, 2026, 19:15Michelle Leona Cecil: Comprehensive Hemophilia Care Doesn’t Begin and End With One Appointment
-
Sep 5, 2026, 19:13Amparo Santamaria: Stem Cells and Hematology – Unlocking a New Frontier in Ovarian Regeneration
-
Sep 5, 2026, 19:10Strengthening the Public Health System for Blood Disorders – Hemophilia Federation of America
-
Sep 5, 2026, 19:08Deidra D. Harris: Supporting Hemophilia of Georgia and the Bleeding Disorders Community
-
Sep 5, 2026, 19:06Katherine Blackwell: Blessed to Have the Opportunity to Speak at the Hemophilia of Indiana Annual Meeting
-
Sep 5, 2026, 19:04Christy V.: What You Need to Know about GI Bleeding and Hemophilia